For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| CG100649 2mg | once daily for 28 days | None | None | 0 | 40 | 13 | 40 | View |
| CG100649 4mg, | once daily for 28 days | None | None | 0 | 42 | 22 | 42 | View |
| Celecoxib 200mg | once daily for 28 dyas | None | None | 0 | 43 | 10 | 43 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal Pain Upper | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 13.1 | View |
| face edema | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA version 13.1 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA version 13.1 | View |
| Nasopharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 13.1 | View |
| chest discomfort | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA version 13.1 | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA version 13.1 | View |